Vext Science, Inc. (VEXT.CN)
CAD 0.13
(4.0%)
CAD 0.13
(4.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 16.76 Million USD | -88.03% |
| 2022 | 15.18 Million USD | 20.27% |
| 2021 | 12.34 Million USD | 138.58% |
| 2020 | 5.52 Million USD | 21.02% |
| 2019 | 4.56 Million USD | -19.65% |
| 2018 | 6.19 Million CAD | -10.25% |
| 2017 | 6.13 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 218.22 Thousand USD | 110.82% |
| 2024 Q1 | -173.29 Thousand USD | -116.84% |
| 2023 Q3 | 452.87 Thousand USD | -80.25% |
| 2023 Q2 | 2.29 Million USD | -3.76% |
| 2023 Q4 | -2.54 Million USD | -662.76% |
| 2023 Q1 | 2.38 Million USD | -14.47% |
| 2023 FY | - USD | -88.03% |
| 2022 Q2 | 4.21 Million USD | -37.53% |
| 2022 Q1 | 6.73 Million USD | 99.19% |
| 2022 FY | - USD | 20.27% |
| 2022 Q3 | 2.81 Million USD | -33.08% |
| 2022 Q4 | 2.78 Million USD | -1.11% |
| 2021 Q3 | 3.56 Million USD | -7.53% |
| 2021 Q2 | 3.85 Million USD | 55.4% |
| 2021 Q1 | 2.47 Million USD | 13.19% |
| 2021 FY | - USD | 138.58% |
| 2021 Q4 | 3.38 Million USD | -5.02% |
| 2020 FY | - USD | 21.02% |
| 2020 Q1 | -644.99 Thousand USD | 32.69% |
| 2020 Q4 | 2.18 Million USD | -13.25% |
| 2020 Q3 | 2.52 Million USD | 93.18% |
| 2020 Q2 | 1.3 Million USD | 302.61% |
| 2019 FY | - USD | -19.65% |
| 2019 Q2 | 1.75 Million USD | -27.68% |
| 2019 Q1 | 2.42 Million USD | 321.81% |
| 2019 Q4 | -958.29 Thousand USD | -170.77% |
| 2019 Q3 | 1.35 Million USD | -22.63% |
| 2018 Q2 | 1.35 Million USD | -12.58% |
| 2018 Q3 | 2.18 Million USD | 61.22% |
| 2018 Q4 | 573.72 Thousand USD | -73.8% |
| 2018 FY | - CAD | -10.25% |
| 2018 Q1 | 1.55 Million USD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 376.065% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 933.993% |
| Blueberries Medical Corp. | -1.22 Million CAD | 1472.361% |
| The BC Bud Corporation | -1.19 Million CAD | 1501.936% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 358.571% |
| CordovaCann Corp. | -1.6 Million CAD | 1146.248% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 739.134% |
| Captor Capital Corp. | 2.42 Million CAD | -592.531% |
| City View Green Holdings Inc. | -2.01 Million CAD | 932.349% |
| 1CM Inc. | 1.31 Million CAD | -1176.515% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 67729.391% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 859.256% |
| IM Cannabis Corp. | -2.79 Million CAD | 700.98% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 480.878% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 4375.031% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 625.129% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | -1368.758% |
| Ovation Science Inc. | -778.83 Thousand CAD | 2252.885% |
| Pharmadrug Inc. | -1.33 Million CAD | 1355.969% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 376.868% |
| RAMM Pharma Corp. | -6.3 Million CAD | 366.06% |
| RIV Capital Inc. | -20.28 Million CAD | 182.678% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 399.684% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 121.61% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 668.247% |
| 1933 Industries Inc. | -10.03 Million CAD | 267.123% |
| Red Light Holland Corp. | -5.25 Million CAD | 419.022% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 2283.269% |
| Xebra Brands Ltd. | -1.49 Million CAD | 1221.565% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 1288.109% |